Bcl-Xl protein expression in laryngeal squamous cell carcinoma

Clinical Otolaryngology and Allied Sciences

Volumn 29, Issue 1, 2004, Pages 55-58

  Krecicki, T ^a,b   Fraczek, M ^a   Kozlak, J ^a   Zatonski, T ^a   Jelen, M ^a   Dus, D ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Dept and Clinic of Otolaryngology ^*  (Poland)

Author keywords

Bcl Xl protein; DNA ploidy; Immunohistochemistry; Laryngeal cancer; Proliferative activity

Indexed keywords

PROTEIN BCL 10;

ADULT; AGE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX CANCER; LYMPH NODE; MALE; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; APOPTOSIS; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PLOIDIES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 1642503941     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2273.2004.00780.x     Document Type: Article

References (19)

1. REED J.C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6
2. CHERBONNEL-LASSERRE C., GAUNEY S. & KRONENBERG A. (1996) Suppression of apoptosis by Bcl-2 or Bcl-Xl promotes susceptibility to mutagenesis. Oncogene 13, 1489-1497
3. BOISE L.H., GONZALEZ-GARCIA M., POSTEMA C.E. et al. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator apoptotic cell death. Cell 74, 597-609
4. KRAJEWSKI S., KRAJEWSKA M., SHABAIK A. et al. (1994) Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54, 5501-5507
5. TORZEWSKI M., SARBIA M., HEEP H. et al. (1998) Expression of Bcl-Xl, an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin. Cancer Res. 4, 577-583
6. KRAJEWSKA M., MOSS S.F., KRAJEWSKI S. et al. (1996) Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 56, 2422-2427
7. PENA J.C., THOMPSON C.B., RECANT W. et al. (1999) Bcl-xl and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 1, 164-170
8. MINN A.J., RUDIN C.M., BOISE L.H. et al. (1995) Expression of Bcl-Xl can confer a multidrug resistance phenotype. Blood 86, 1903-1910
9. FANIDI A., HARRINGTON E.A. & EVAN G.I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554-556
10. NATSUGOE S., MATSUMOTO M., OKUMURA H. et al. (2001) Bax and Bcl-Xl expressions are not related to prognosis in patients with advanced esophageal squamous cell carcinoma. Cancer Lett. 174, 91-97
11. TAKAYAMA T., NAGAO M., SAWADA H. et al. (2001) Bcl-X expression in esophageal squamous cell carcinoma: association with tumour progression and prognosis. J. Surg. Oncol. 78, 116-123
12. WHISLER L.C., WOOD N.B., CALDARELLI D.D. et al. (1998) Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope 108, 630-638
13. OLOPADE O.I., ADEYANJU M.O., SAFA A.R. et al. (1997) Overexpression of BCL-x protein in primary breast cancer is associated with high tumour grade and nodal metastases. Cancer J. Sci. Am. 3, 230-237
14. SASATOMI E., TOKUNAGA O. & MIYAZAKI K. (1996) Spontaneous apoptosis in gallbladder carcinoma: relationships with clinicopathological factors, expression of E-cadherin, bcl-2 potooncogene and bcl-2 oncosuppressor gene. Cancer 78, 2101-2110
15. BASOLO F., POLLINA L., FONTANINI G. et al. (1997) Apoptosis proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. Br. J. Cancer 75, 537-541
16. DE ANGELIS P.M., STOKKE T., THORSTENSEN L. et al. (1998) Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. Mol. Pathol. 51, 254-261
17. BUCCI B., CARICO E., RINALDI A. et al. (2001) Biological indicators of aggressiveness in T1 ductal invasive breast cancer. Anticancer Res. 21, 2949-2955
18. MAFFINI M.V., ORTEGA H.H., STOKER C. et al. (2001) Bcl-2 correlates with tumour ploidy and nuclear morphology in early stage prostate carcinoma. A fine needle aspiration biopsy study. Pathol. Res. Pract. 197, 487-492
19. SINICROPE F.A., HART J., MICHELASSI F. et al. (1995) Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin. Cancer Res. 1, 1103-1110